Mebrofenin (AnazaoHealth Corporation)


Welcome to the PulseAid listing for the Mebrofenin drug offered from AnazaoHealth Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AnazaoHealth Corporation
NON-PROPRIETARY NAME: Mebrofenin
SUBSTANCE NAME: MEBROFENIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2012-06-19
END MARKETING DATE: 0000-00-00


Mebrofenin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMebrofenin from AnazaoHealth Corporation
LABELER NAME: AnazaoHealth Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/1)
START MARKETING DATE: 2012-06-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51808-216_4d7406b4-8bcd-40f0-a31f-975f5b811da7
PRODUCT NDC: 51808-216
APPLICATION NUMBER:

Other MEBROFENIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationMebrofenin
Bracco Diagnostics IncCholetec
Pharmalucence, Inc.Kit for the Preparation of Technetium Tc 99m Mebrofenin